APLM

Apollomics (APLM)

Apollomics Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:APLM

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
08/13/2024	10:50AM	AllPennyStocks.com	Biotech Sees Massive Buying Pressure Following Phase 2 Preliminary Data	NASDAQ:APLM	Apollomics Inc
06/04/2024	8:00AM	GlobeNewswire Inc.	Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:APLM	Apollomics Inc
05/29/2024	8:00AM	GlobeNewswire Inc.	Apollomics Announces Presentation at the 2024 BIO International Convention	NASDAQ:APLM	Apollomics Inc
05/08/2024	4:05PM	GlobeNewswire Inc.	Apollomics Announces Private Placement Financing and Addition to Board of Directors	NASDAQ:APLM	Apollomics Inc
04/25/2024	8:30AM	GlobeNewswire Inc.	Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene	NASDAQ:APLM	Apollomics Inc
04/10/2024	7:00AM	GlobeNewswire Inc.	Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:APLM	Apollomics Inc
04/02/2024	8:00AM	GlobeNewswire Inc.	Apollomics Announces Poster Presentations of Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:APLM	Apollomics Inc
03/28/2024	7:00AM	GlobeNewswire Inc.	Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results	NASDAQ:APLM	Apollomics Inc
03/26/2024	8:00AM	GlobeNewswire Inc.	Apollomics to Announce Full Year 2023 Financial Results and Host Conference Call on March 28, 2024	NASDAQ:APLM	Apollomics Inc
03/04/2024	7:00AM	GlobeNewswire Inc.	Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer	NASDAQ:APLM	Apollomics Inc
02/07/2024	7:00AM	GlobeNewswire Inc.	Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:APLM	Apollomics Inc
01/19/2024	4:15PM	GlobeNewswire Inc.	Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	NASDAQ:APLM	Apollomics Inc
01/17/2024	4:30PM	GlobeNewswire Inc.	Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference	NASDAQ:APLM	Apollomics Inc
01/03/2024	7:00AM	GlobeNewswire Inc.	Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia	NASDAQ:APLM	Apollomics Inc
01/02/2024	4:30PM	GlobeNewswire Inc.	Apollomics to Present at the 2024 Biotech Showcase	NASDAQ:APLM	Apollomics Inc
12/04/2023	7:00AM	GlobeNewswire Inc.	Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation	NASDAQ:APLM	Apollomics Inc
11/29/2023	7:30AM	GlobeNewswire Inc.	Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	NASDAQ:APLM	Apollomics Inc
11/28/2023	7:00AM	GlobeNewswire Inc.	Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)	NASDAQ:APLM	Apollomics Inc
11/16/2023	8:30AM	GlobeNewswire Inc.	Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer	NASDAQ:APLM	Apollomics Inc
10/31/2023	8:30AM	GlobeNewswire Inc.	Apollomics Announces Two New Cohorts in Global Phase 2 SPARTA Study of Vebreltinib in Non-Small Cell Lung Cancer and Other Solid Tumors with MET Dysregulation	NASDAQ:APLM	Apollomics Inc
10/26/2023	8:50AM	GlobeNewswire Inc.	Apollomics Announces Report of Activity of Vebreltinib in Glioblastoma Multiforme (GBM) with PTPRZ-MET Fusion	NASDAQ:APLM	Apollomics Inc
10/23/2023	8:30AM	GlobeNewswire Inc.	Apollomics Announces Efficacy of Vebreltinib in NSCLC Patients with MetEx14 Skipping Mutation Achieving an Overall Response Rate (ORR) of 75%	NASDAQ:APLM	Apollomics Inc
10/16/2023	6:55PM	GlobeNewswire Inc.	Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023	NASDAQ:APLM	Apollomics Inc
09/28/2023	4:17PM	GlobeNewswire Inc.	Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update	NASDAQ:APLM	Apollomics Inc
09/06/2023	7:00AM	GlobeNewswire Inc.	Apollomics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:APLM	Apollomics Inc
04/11/2023	8:30AM	GlobeNewswire Inc.	Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium	NASDAQ:APLM	Apollomics Inc
04/10/2023	9:01AM	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:APLM	Apollomics Inc
03/31/2023	4:01PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:APLM	Apollomics Inc
03/31/2023	7:40AM	PR Newswire (US)	Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq	NASDAQ:APLM	Apollomics Inc
03/31/2023	7:34AM	PR Newswire (US)	Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq	NASDAQ:APLM	Apollomics Inc